Aetion and NICE Partner to Leverage RWE in Comparative Effectiveness Studies

Aetion and the National Institute for Health and Care Excellence (NICE) have announced a partnership intended to advance comparative effectiveness studies using real world evidence (RWE). Results will inform NICE decision-making.

Aetion CEO Carolyn Magill remarks, “We are honored to help NICE further advance evidence-based decision-making,” adding, “Through the scientific rigor embedded in the Aetion Evidence Platform, NICE can more easily integrate high quality RWE into decisions ranging from health technology assessments to clinical guidance development.” Read more here.

(Source: Cision PR Newswire, 10/6/21)